Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
CareDx
4401
CareDx
Health
Fitness
Health and Wellness
Health Care
Technology
Biotechnology
AlloMap is a way to non-invasively test cardiac transplant patients for their risk of acute cellular rejection, graft failure, and death.
Suggest edits
Founded
2000
Raised
$150M
Follow us
Companies in the same industry
Deep Longevity
Elysium Health
Restored Hearing
Fitmo
FitWell
Nozpad
Care/of
Zai Lab
Atlas Biomed
Twitter
Alexa global traffic share
Twitter followers
Overview
Funding
8
Add info
Add round
15 Mar
2017
$25,000,000
Post-IPO debt
CareDx Closes New $25 Million Debt Facility
GlobeNewswire News Room
17 Jun
2016
$22,170,000
Post-IPO equity
SEC FORM D/A
sec
12 Sep
2012
$15,000,000
Debt financing
31 Jan
2011
$12,500,000
Grant
07 Oct
2009
$14,400,000
Venture capital
05 Aug
2009
$14,400,000
Venture capital (Series F)
05 Jan
2006
$26,500,000
Venture capital
01 Dec
2004
$20,000,000
Venture capital (Series D)
